USFDA accelerates biosimilar approvals process in the US — Four stocks that could benefit

Such a move will be positive for Indian drugmakers such as Biocon, Dr. Reddy’s Laboratories, Lupin and Sun Pharma, who have exposure to the biosimilars market in the US.








